We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 79

Global personal care products industry expected to hit $630 billion by 2017

  • Shook Hardy & Bacon LLP
  • -
  • Global
  • -
  • May 10 2013

International research firm Research and Markets has issued a report which observes that the "global personal care products industry" has experienced

Rapid biosimilar growth seen through 2023

  • Shook Hardy & Bacon LLP
  • -
  • Global
  • -
  • May 16 2013

British market-research firm Visiongain has forecast a $2.445-billion global market for biosimilars in 2013, a 20-percent increase over 2012, with

Scientists push for global action on EDCs

  • Shook Hardy & Bacon LLP
  • -
  • Global
  • -
  • May 10 2013

A group of scientists has written a letter to the United Nations Environment Program (UNEP), World Health Organization (WHO), Organization for

Avian influenza (H7N9) deemed “one of the most lethal” by WHO leader

  • Shook Hardy & Bacon LLP
  • -
  • Global
  • -
  • April 26 2013

The World Health Organization (WHO) recently released the results of its preliminary investigation into a new strain of avian influenza A (H7N9

Russia’s accession to the WTO: legal consequences for the pharmaceutical business

  • CMS, Russia
  • -
  • Global, Russia
  • -
  • March 16 2012

On 16 December 2011, the protocol on Russia’s accession to the World Trade Organization (WTO) was signed

Chem trust investigates chemical causes of obesity

  • Shook Hardy & Bacon LLP
  • -
  • Global, United Kingdom
  • -
  • March 23 2012

The U.K.-based Chemicals, Health and Environment Monitoring (CHEM) Trust has issued a March 2012 report claiming that recent studies have linked “hormone disrupting chemicals in food and consumer products” to obesity and Type 2 diabetes in humans

Understanding the global transparency landscape: the beginning of an ongoing journey

  • Porzio Bromberg & Newman PC
  • -
  • Global
  • -
  • February 25 2013

The quest for transparency in the relationships between life sciences companies and healthcare professionals has become a global movement, as

Celebrity endorsements blamed for kids’ “junk” food choices

  • Shook Hardy & Bacon LLP
  • -
  • Global, USA
  • -
  • March 15 2013

A University of Liverpool study contends that "celebrity endorsement of a food product encourages children to eat more of the endorsed product." The

Social medicine?

  • Drinker Biddle & Reath LLP
  • -
  • Global
  • -
  • August 20 2012

It isn’t difficult to see that the main impact of social media penetration in our culture is an epidemic of oversharing

Strategic risk management for biotechnology companies

  • Gowling Lafleur Henderson LLP
  • -
  • Canada, Global
  • -
  • August 1 2008

Ernst & Young has released a report identifying the top 10 strategic risks facing biotechnology companies over the next 5 years

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy